Profil
Mark Ungs is the founder of InterValve, Inc. which he founded in 2008 and where he currently holds the titles of President, Chief Executive Officer & Director.
Mr. Ungs is also the founder of ACTx, Inc. (Georgia).
He previously worked as Vice President-New Business Development at Boston Scientific Corp.
Mr. Ungs completed his undergraduate degree at Oregon State University and earned an MBA from the University of California, Berkeley.
Aktive Positionen von Mark Ungs
| Unternehmen | Position | Beginn |
|---|---|---|
InterValve, Inc.
 InterValve, Inc. Medical SpecialtiesHealth Technology InterValve, Inc. operates as a medical device company which develops aortic valvuloplasty balloons for treatment of calcific aortic stenosis. Its V8 product is enhanced with leaflet hyperextension without increasing the risk of annulus over-distension. The firm also develops tools for the percutaneous and trans-apical aortic valve replacement procedure. The company was founded by Wes Pedersen, Mark Ungs, Robert S. Schwartz and Robert A. Van Tassel in 2008 and is headquartered in Plymouth, MN. | Gründer | 01.01.2008 |
| ACTx, Inc. (Georgia) | Gründer | - |
Ehemalige bekannte Positionen von Mark Ungs
| Unternehmen | Position | Ende |
|---|---|---|
| BOSTON SCIENTIFIC CORPORATION | Corporate Officer/Principal | - |
Ausbildung von Mark Ungs
| Oregon State University | Undergraduate Degree |
| University of California, Berkeley | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| BOSTON SCIENTIFIC CORPORATION | Health Technology |
| Private Unternehmen | 2 |
|---|---|
InterValve, Inc.
InterValve, Inc. Medical SpecialtiesHealth Technology InterValve, Inc. operates as a medical device company which develops aortic valvuloplasty balloons for treatment of calcific aortic stenosis. Its V8 product is enhanced with leaflet hyperextension without increasing the risk of annulus over-distension. The firm also develops tools for the percutaneous and trans-apical aortic valve replacement procedure. The company was founded by Wes Pedersen, Mark Ungs, Robert S. Schwartz and Robert A. Van Tassel in 2008 and is headquartered in Plymouth, MN. | Health Technology |
| ACTx, Inc. (Georgia) |
